Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$25K Buy
170
+1
+0.6% +$149 0.23% 39
2015
Q4
$27K Sell
169
-264
-61% -$41.5K 0.24% 35
2015
Q3
$60K Sell
433
-307,495
-100% -$48.5M 0.55% 38
2015
Q2
$47.3M Buy
307,928
+35,316
+13% +$5.66M 0.64% 34
2015
Q1
$43.6M Sell
272,612
-16,240
-6% -$2.56M 0.66% 32
2014
Q4
$46M Buy
288,852
+23,150
+9% +$3.61M 0.66% 33
2014
Q3
$37.3M Buy
265,702
+1,062
+0.4% +$139K 0.6% 34
2014
Q2
$31.3M Buy
264,640
+16,877
+7% +$1.95M 0.5% 40
2014
Q1
$30.6M Sell
247,763
-18,302
-7% -$2.22M 0.55% 37
2013
Q4
$30.4M Buy
266,065
+8,127
+3% +$924K 0.51% 42
2013
Q3
$28.9M Buy
257,938
+2,217
+0.9% +$240K 0.55% 37
2013
Q2
$25.2M Buy
+255,721
New +$26.5M 0.5% 36

Other funds holding AMGN

TD Securities (USA)'s AMGN Position: Q1 2016 in Review

TD Securities (USA) increased its Amgen (AMGN) stake by 0.59% in Q1 2016, buying an estimated $149 and bringing the position to 170 shares worth $25K. The position accounts for 0.23% of the portfolio, ranked #39.

TD Securities (USA) first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $47.3M in Q2 2015. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • TD Securities (USA) held 170 shares of Amgen worth $25K as of Q1 2016.
  • TD Securities (USA) bought 1 Amgen share in Q1 2016, an estimated $149.
  • Amgen made up 0.23% of TD Securities (USA)'s portfolio in Q1 2016, its #39 holding.
  • TD Securities (USA) first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s Amgen position peaked at $47.3M in Q2 2015.
  • 1,435 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.